A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

INZY Insider Trading (Inozyme Pharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.72%

Insider Buying (Last 12 Months): $9,298,246.50

Insider Selling (Last 12 Months): $0.00

Inozyme Pharma Insider Trading History Chart

Inozyme Pharma Share Price & Price History

^$3.54

▲ +0.13 (3.81%)

As of 08/10/2022 01:00 AM ET

Days: 30 | 90 | 365

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

Inozyme Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/19/2022	Axel Bolte	CEO	Buy	67,750	$3.69	$249,997.50	258,575
4/19/2022	Henric Bjorn Bjarke	COO	Buy	27,100	$3.69	$99,999.00	80,626
4/19/2022	Longitude Capital Partners Iii	Major Shareholder	Buy	1,355,000	$3.69	$4,999,950.00	4,174,379
4/19/2022	Robert Lorne Hopfner	Director	Buy	1,070,000	$3.69	$3,948,300.00	2,661,154
6/24/2021	Axel Bolte	CEO	Sell	66,788	$0.00	$0.00	257,613
1/28/2021	Holdings A/S Novo	Major Shareholder	Sell	375,000	$21.00	$7,875,000.00	2,194,379
7/28/2020	Longitude Capital Partners Iii	Major Shareholder	Buy	625,000	$16.00	$10,000,000.00
7/28/2020	Robert Lorne Hopfner	Director	Buy	187,500	$16.00	$3,000,000.00

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Inozyme Pharma (NASDAQ:INZY)

Institutional Buying and Selling by Quarter

Inozyme Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/8/2022	Walleye Capital LLC	101,442	$0.48M	0.0%	N/A	0.253%
6/7/2022	Bank of America Corp DE	6,647	$28K	0.0%	-43.9%	0.017%
5/17/2022	Rock Springs Capital Management LP	1,193,195	$4.88M	0.1%	+37.4%	5.009%
5/16/2022	PDT Partners LLC	10,273	$42K	0.0%	N/A	0.043%
5/13/2022	Renaissance Technologies LLC	11,900	$49K	0.0%	N/A	0.050%
5/13/2022	Northern Trust Corp	113,823	$0.47M	0.0%	-5.7%	0.478%
5/13/2022	Charles Schwab Investment Management Inc.	30,497	$0.13M	0.0%	-16.3%	0.128%
5/12/2022	BlackRock Inc.	878,400	$3.59M	0.0%	+4.9%	3.688%
5/12/2022	Citigroup Inc.	12,517	$51K	0.0%	+241.6%	0.053%
5/11/2022	JPMorgan Chase & Co.	310,933	$1.27M	0.0%	-4.1%	1.305%
2/15/2022	Laurion Capital Management LP	13,390	$91K	0.0%	-81.1%	0.057%
2/15/2022	Adage Capital Partners GP L.L.C.	1,599,028	$10.91M	0.0%	+8.9%	6.757%
2/14/2022	Suvretta Capital Management LLC	1,013,216	$6.91M	0.1%	+2.7%	4.281%
2/11/2022	Bioimpact Capital LLC	302,615	$2.06M	0.4%	-5.6%	1.279%
2/8/2022	Northern Trust Corp	120,762	$0.82M	0.0%	+4.0%	0.510%
2/2/2022	New York State Common Retirement Fund	3,834	$26K	0.0%	-63.3%	0.016%
11/16/2021	Suvretta Capital Management LLC	986,400	$11.43M	0.2%	+170.1%	4.168%
11/16/2021	Wellington Management Group LLP	364,600	$4.23M	0.0%	-50.0%	1.541%
11/16/2021	Laurion Capital Management LP	70,700	$0.82M	0.0%	N/A	0.299%
11/16/2021	BioImpact Capital LLC	320,724	$3.72M	0.6%	N/A	1.355%
11/16/2021	CHI Advisors LLC	920,264	$10.67M	3.1%	-0.8%	3.889%
11/15/2021	Deerfield Management Company L.P. Series C	2,344,786	$27.18M	0.5%	+7.6%	9.910%
11/15/2021	Rock Springs Capital Management LP	850,015	$9.85M	0.2%	+1.2%	3.592%
11/15/2021	Marshall Wace LLP	33,408	$0.39M	0.0%	-16.9%	0.141%
11/15/2021	Caas Capital Management LP	135,398	$1.57M	0.0%	N/A	0.572%
11/12/2021	Geode Capital Management LLC	198,624	$2.30M	0.0%	+10.5%	0.839%
11/8/2021	Russell Investments Group Ltd.	115,516	$1.34M	0.0%	+4,518.8%	0.488%
11/2/2021	New York State Common Retirement Fund	10,453	$0.12M	0.0%	+18.8%	0.044%
11/1/2021	SG Americas Securities LLC	11,611	$0.14M	0.0%	N/A	0.049%
8/25/2021	Marshall Wace LLP	40,202	$0.69M	0.0%	-22.4%	0.170%
8/17/2021	Millennium Management LLC	61,313	$1.05M	0.0%	-58.9%	0.259%
8/17/2021	Burrage Capital Management LLC	242,517	$4.13M	4.1%	+43.1%	1.025%
8/17/2021	Citadel Advisors LLC	171,066	$2.92M	0.0%	-28.8%	0.723%
8/16/2021	California State Teachers Retirement System	19,867	$0.34M	0.0%	+9.5%	0.084%
8/16/2021	Charles Schwab Investment Management Inc.	61,917	$1.06M	0.0%	+4.1%	0.262%
8/16/2021	State Street Corp	169,889	$2.90M	0.0%	+28.5%	0.718%
8/16/2021	Nuveen Asset Management LLC	47,394	$0.81M	0.0%	+122.6%	0.200%
8/16/2021	Goldman Sachs Group Inc.	19,310	$0.33M	0.0%	-18.8%	0.082%
8/16/2021	Marshall Wace LLP	40,202	$0.69M	0.0%	-22.4%	0.170%
8/13/2021	Northern Trust Corp	120,743	$2.06M	0.0%	+4.6%	0.514%
8/13/2021	Geode Capital Management LLC	179,672	$3.06M	0.0%	+19.5%	0.765%
8/13/2021	Vanguard Group Inc.	335,286	$5.71M	0.0%	-1.7%	1.428%
8/12/2021	JPMorgan Chase & Co.	16,659	$0.28M	0.0%	-21.9%	0.071%
8/11/2021	Bank of New York Mellon Corp	36,546	$0.62M	0.0%	+56.6%	0.156%
8/11/2021	BlackRock Inc.	899,873	$15.34M	0.0%	+4.4%	3.832%
8/10/2021	Citigroup Inc.	2,108	$36K	0.0%	+69.3%	0.009%
8/5/2021	Rhumbline Advisers	12,787	$0.22M	0.0%	N/A	0.054%
8/4/2021	Russell Investments Group Ltd.	2,501	$42K	0.0%	N/A	0.011%
8/2/2021	New York State Common Retirement Fund	8,802	$0.15M	0.0%	-28.4%	0.037%
5/18/2021	Millennium Management LLC	149,205	$2.95M	0.0%	N/A	0.635%
5/18/2021	Citadel Advisors LLC	240,401	$4.76M	0.0%	-4.8%	1.024%
5/18/2021	California State Teachers Retirement System	18,143	$0.36M	0.0%	+47.5%	0.077%
5/17/2021	Deerfield Management Company L.P. Series C	1,964,000	$38.89M	0.8%	+70.7%	8.363%
5/17/2021	Rock Springs Capital Management LP	827,900	$16.39M	0.4%	-0.3%	3.526%
5/17/2021	Suvretta Capital Management LLC	341,427	$6.76M	0.1%	+59.3%	1.454%
5/17/2021	Caas Capital Management LP	177,502	$3.52M	0.0%	N/A	0.756%
5/17/2021	Novo Holdings A S	1,969,379	$38.99M	1.6%	-23.4%	8.386%
5/17/2021	Goldman Sachs Group Inc.	23,790	$0.47M	0.0%	+14.2%	0.101%
5/13/2021	Bank of New York Mellon Corp	23,337	$0.46M	0.0%	+9.3%	0.099%
5/13/2021	Citigroup Inc.	1,245	$25K	0.0%	-44.3%	0.005%
5/12/2021	Northern Trust Corp	115,469	$2.29M	0.0%	+24.4%	0.492%
5/12/2021	Geode Capital Management LLC	150,361	$2.98M	0.0%	+41.3%	0.641%
5/12/2021	JPMorgan Chase & Co.	21,324	$0.42M	0.0%	+455.9%	0.091%
5/11/2021	New York State Common Retirement Fund	12,300	$0.24M	0.0%	+66.2%	0.052%
5/7/2021	BlackRock Inc.	861,683	$17.06M	0.0%	+36.6%	3.671%
5/7/2021	American International Group Inc.	7,011	$0.14M	0.0%	+48.4%	0.030%
5/4/2021	Commonwealth Equity Services LLC	65,781	$1.30M	0.0%	N/A	0.280%
3/12/2021	DekaBank Deutsche Girozentrale	7,000	$0.17M	0.0%	N/A	0.030%
2/19/2021	JPMorgan Chase & Co.	3,836	$79K	0.0%	+26.6%	0.016%
2/16/2021	Baker BROS. Advisors LP	106,999	$2.21M	0.0%	-9.7%	0.458%
2/16/2021	Nuveen Asset Management LLC	21,292	$0.44M	0.0%	+24.7%	0.091%
2/16/2021	Avidity Partners Management LP	9,683	$0.20M	0.0%	-84.3%	0.041%
2/16/2021	Charles Schwab Investment Management Inc.	49,045	$1.01M	0.0%	+1.5%	0.210%
2/12/2021	CHI Advisors LLC	995,396	$20.55M	5.8%	-1.4%	4.259%
2/11/2021	Citigroup Inc.	2,236	$46K	0.0%	+473.3%	0.010%
2/9/2021	Wells Fargo & Company MN	9,696	$0.20M	0.0%	+58.6%	0.041%
2/9/2021	Pivotal bioVenture Partners Investment Advisor LLC	1,591,154	$32.84M	10.8%	N/A	6.808%
2/9/2021	Bank of New York Mellon Corp	21,349	$0.44M	0.0%	+10.1%	0.091%
2/8/2021	New York State Common Retirement Fund	7,400	$0.15M	0.0%	N/A	0.032%
2/5/2021	BlackRock Inc.	630,751	$13.02M	0.0%	+25.9%	2.699%
2/4/2021	State of Wisconsin Investment Board	11,400	$0.24M	0.0%	N/A	0.049%
12/30/2020	Deerfield Management Company L.P. Series C	1,150,299	$30.24M	0.6%	N/A	4.921%
12/14/2020	Strs Ohio	2,000	$52K	0.0%	N/A	0.009%
11/17/2020	California State Teachers Retirement System	12,298	$0.32M	0.0%	N/A	0.053%
11/16/2020	State of Tennessee Treasury Department	9,044	$0.24M	0.0%	N/A	0.039%
11/13/2020	Morgan Stanley	1,251	$33K	0.0%	N/A	0.005%
11/13/2020	Charles Schwab Investment Management Inc.	48,334	$1.27M	0.0%	N/A	0.207%
11/13/2020	Sofinnova Investments Inc.	2,028,308	$53.32M	4.0%	N/A	8.681%
11/12/2020	JPMorgan Chase & Co.	3,029	$72K	0.0%	N/A	0.013%
11/12/2020	Yale University	113,502	$2.98M	9.1%	N/A	0.486%
11/12/2020	Sphera Funds Management LTD.	196,411	$5.16M	0.5%	N/A	0.841%
11/10/2020	State Street Corp	70,585	$1.86M	0.0%	N/A	0.302%
11/6/2020	NEA Management Company LLC	2,444,379	$64.26M	2.7%	N/A	10.462%
11/6/2020	BlackRock Inc.	500,934	$13.17M	0.0%	N/A	2.144%
11/5/2020	California Public Employees Retirement System	16,011	$0.42M	0.0%	N/A	0.069%

Data available starting January 2016

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $3.54

$3.41

$3.69

50 Day Range

MA: $4.37

$3.20

$5.45

52 Week Range

Now: $3.54

$3.15

$17.55

Volume

42,913 shs

Average Volume

178,509 shs

Market Capitalization

$141.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.09

Who are the company insiders with the largest holdings of Inozyme Pharma?: Inozyme Pharma's top insider investors include:
Longitude Capital Partners Iii (Major Shareholder)
Robert Lorne Hopfner (Director)
Holdings A/S Novo (Major Shareholder)
Axel Bolte (CEO)
Henric Bjorn Bjarke (COO)
Learn More about top insider investors at Inozyme Pharma.
Who are the major institutional investors of Inozyme Pharma?: Inozyme Pharma's top institutional investors include:
Walleye Capital LLC — 0.25%
Learn More about top institutional investors of Inozyme Pharma stock.
Which institutional investors are buying Inozyme Pharma stock?: Within the last quarter, INZY stock was purchased by institutional investors including:
Walleye Capital LLC
Within the previous year, these company insiders have bought Inozyme Pharma stock:
Longitude Capital Partners Iii (Major Shareholder)
Robert Lorne Hopfner (Director)
Holdings A/S Novo (Major Shareholder)
Axel Bolte (CEO)
Learn More investors buying Inozyme Pharma stock.